TipRanks
Sonoma Pharmaceuticals (SNOA)
NASDAQ:SNOA
US Market
SNOA
Sonoma Pharmaceuticals
RESEARCH TOOLSreports
Want to see SNOA full AI Analyst Report?

Sonoma Pharmaceuticals (SNOA) Income Statement

355 Followers

Sonoma Pharmaceuticals Income Statement

Last quarter (Q1 2027), Sonoma Pharmaceuticals's total revenue was $6.41M, an increase of 70.64% from the same quarter last year. In Q1, Sonoma Pharmaceuticals's net income was $-330.00K. See Sonoma Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Jun 22
Total Revenue
$ 19.53M$ 14.29M$ 12.73M$ 13.27M$ 12.63M
Gross Profit
$ 7.42M$ 5.46M$ 4.75M$ 4.48M$ 3.99M
Operating Expenses
$ 9.88M$ 9.18M$ 9.45M$ 9.05M$ 9.88M
Depreciation and Amortization
$ 139.00K$ 138.00K$ 176.00K$ 125.00K$ 186.00K
EBITDA
$ -2.32M$ -2.77M$ -4.86M$ -5.06M$ -5.22M
Operating Income
$ -2.46M$ -3.71M$ -4.70M$ -4.57M$ -5.89M
Other Income/Expenses
$ -958.00K$ 803.00K$ -330.00K$ -614.00K$ 469.00K
Pretax Income
$ -3.42M$ -2.91M$ -5.03M$ -5.18M$ -5.42M
Net Income
$ -3.17M$ -3.46M$ -4.83M$ -5.15M$ -5.09M
Per Share Metrics
Basic EPS
$ -1.89$ -2.79$ -5.32$ -15.18$ -19.17
Diluted EPS
$ -1.89$ -2.79$ -5.32$ -15.18$ -19.17
Weighted Average Shares Outstanding
 1.68M 1.24M 909.00K 339.40K 265.30K
Weighted Average Shares Outstanding (Diluted)
 1.68M 1.24M 909.00K 339.40K 265.30K
Currency in USD

Sonoma Pharmaceuticals Earnings and Revenue History